Recursion Pharmaceuticals, Inc. RXRX Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s change in other assets?
- Recursion Pharmaceuticals, Inc. (RXRX) reported change in other assets of -$14.75M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s change in other assets changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s change in other assets decreased by 204.7% year-over-year, from -$4.84M to -$14.75M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.